Biosynex Stock Net Income
| ALBIO Stock | EUR 2.60 0.08 2.99% |
Biosynex fundamentals help investors to digest information that contributes to Biosynex's financial success or failures. It also enables traders to predict the movement of Biosynex Stock. The fundamental analysis module provides a way to measure Biosynex's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biosynex stock.
Biosynex |
Biosynex Company Net Income Analysis
Biosynex's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Biosynex Net Income | 104 M |
Most of Biosynex's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biosynex is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Biosynex reported net income of 104 M. This is 69.53% lower than that of the Health Care Equipment & Supplies sector and 39.92% lower than that of the Health Care industry. The net income for all France stocks is 81.78% higher than that of the company.
Biosynex Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biosynex's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biosynex could also be used in its relative valuation, which is a method of valuing Biosynex by comparing valuation metrics of similar companies.Biosynex is currently under evaluation in net income category among its peers.
Biosynex Fundamentals
| Return On Equity | 0.89 | |||
| Return On Asset | 0.45 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 91.77 M | |||
| Shares Outstanding | 10.25 M | |||
| Shares Owned By Insiders | 58.06 % | |||
| Shares Owned By Institutions | 1.58 % | |||
| Price To Earning | 48.98 X | |||
| Price To Book | 0.77 X | |||
| Price To Sales | 0.46 X | |||
| Revenue | 382.53 M | |||
| Gross Profit | 206.41 M | |||
| EBITDA | 139.33 M | |||
| Net Income | 104 M | |||
| Cash And Equivalents | 1.98 M | |||
| Cash Per Share | 0.22 X | |||
| Total Debt | 29.16 M | |||
| Debt To Equity | 17.70 % | |||
| Current Ratio | 1.94 X | |||
| Book Value Per Share | 17.24 X | |||
| Cash Flow From Operations | 109.83 M | |||
| Earnings Per Share | 6.37 X | |||
| Target Price | 37.0 | |||
| Number Of Employees | 320 | |||
| Beta | -2.01 | |||
| Market Capitalization | 121.6 M | |||
| Total Asset | 268.94 M | |||
| Retained Earnings | (5 M) | |||
| Working Capital | 2 M | |||
| Current Asset | 6 M | |||
| Current Liabilities | 4 M | |||
| Z Score | 3.4 | |||
| Annual Yield | 0.17 % | |||
| Net Asset | 268.94 M | |||
| Last Dividend Paid | 2.0 |
About Biosynex Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biosynex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biosynex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biosynex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biosynex Stock Analysis
When running Biosynex's price analysis, check to measure Biosynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosynex is operating at the current time. Most of Biosynex's value examination focuses on studying past and present price action to predict the probability of Biosynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosynex's price. Additionally, you may evaluate how the addition of Biosynex to your portfolios can decrease your overall portfolio volatility.